Key Takeaways
- Ralf Reski’s work with moss has advanced biotechnological applications, producing valuable human proteins and health-promoting oils.
- Moss cultures offer cost-effective, scalable alternatives for drug production, including a recombinant protein for Fabry disease and factor H for immune-related disorders.
- Research emphasizes moss’s ecological significance, including its role in carbon storage and potential recovery of endangered species amidst climate change.
Moss: An Ancient Ally in Biotechnology
Mosses, often overlooked, have a pivotal role in Earth’s history, initially greening the planet and contributing to an oxygen-rich atmosphere. Known for their resilience, mosses can clean polluted air, and plant biotechnologist Ralf Reski from the University of Freiburg sees significant untapped potential in these ancient plants.
Reski, captivated by moss genetics during his undergraduate studies, has devoted his career to exploring their biotechnological applications. Despite initial skepticism from peers who considered moss irrelevant to biotechnology, Reski persisted. He discovered that moss cultures, particularly Physcomitrium patens, offer simpler and more efficient production methods compared to traditional plant cell cultures. These cultures are free from problematic viruses and can be cultivated in large bioreactors without complex media.
Since starting his research, Reski’s moss culture systems have yielded various commodities for skincare, medical therapies, and more. One of the key advantages is that these systems are vegan and do not rely on animal products. In a groundbreaking effort, Reski successfully produced a recombinant human protein, factor H, and the enzyme alpha-galactosidase for treating Fabry disease. The moss-derived alpha-galactosidase entered clinical trials in 2015 and proved to have a competitive edge in trials against its human cell line equivalent.
In addition to human proteins, Reski’s lab has made strides in creating a form of spider silk from moss. This material—a potential game-changer in biomedical applications due to its hypoallergenic properties—could lead to innovative drug delivery techniques. Reski’s team is also leveraging moss for bioactive skincare compounds, underscoring its versatile applications.
Beyond biotechnology, Reski emphasizes the ecological significance of mosses, which play a vital role in regulating carbon cycles. His research includes efforts to cultivate high-performing peat moss clones to combat climate change threats faced by peat bogs. He expresses concern for endangered species like Takakia, a 400-million-year-old moss facing extinction from climate change.
Overall, Reski’s pioneering work not only advances biotechnological applications but also underscores the environmental importance of mosses in combating climate change and preserving biodiversity.
The content above is a summary. For more details, see the source article.
